press clippings GEN Edge: What’s in a Name - Out with Invizyne, In with eXoZymes Feb 15, 2025 5:32:31 AM
press clippings With NREL's Help, GCxN Company Readies for Initial Public Offering Sep 30, 2024 12:00:00 AM
